Search

everythinglearnresearchcommunity

for

Search:↓

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Dutasteride is the most effective for hair loss but may cause sexual and mental side effects.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Most people on isotretinoin had chapped lips, but only a few stopped the medicine due to side effects.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

The combination of finasteride, dutasteride, and minoxidil is generally safe for treating male hair loss with minimal side effects.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Canadian lawsuits involving 5-alpha-reductase inhibitors are related to persistent erectile dysfunction side effects, with no judgments against companies yet.

Male hormones worsen kidney transplant damage, but blocking them helps.

Krill oil may help reduce prostate enlargement and growth.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Spironolactone helps prevent swelling caused by minoxidil in women with hair loss.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

No treatment fully prevents hair loss from chemotherapy yet.

Finasteride and dutasteride do not significantly change beard thickness in men.

Some natural compounds can protect fish ear cells from damage by certain antibiotics without affecting the antibiotics' ability to fight infections.